Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.040 | 13 | 46883917 | intron variant | C/A;G | snv |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||||||
|
1.000 | 0.040 | 13 | 46883917 | intron variant | C/A;G | snv |
|
0.010 | 1.000 | 1 | 2006 | 2006 | |||||||||
|
1.000 | 0.040 | 13 | 46883917 | intron variant | C/A;G | snv |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||||||
|
0.882 | 0.040 | 13 | 46892487 | synonymous variant | G/A | snv | 1.8E-02 | 1.7E-02 |
|
0.010 | 1.000 | 1 | 2007 | 2007 | |||||||
|
0.882 | 0.040 | 13 | 46892487 | synonymous variant | G/A | snv | 1.8E-02 | 1.7E-02 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2003 | 2003 | ||||||
|
0.645 | 0.640 | 13 | 46897343 | upstream gene variant | C/T | snv | 0.40 |
|
Nervous System Diseases; Mental Disorders | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.645 | 0.640 | 13 | 46897343 | upstream gene variant | C/T | snv | 0.40 |
|
Mental Disorders | 0.010 | < 0.001 | 1 | 2016 | 2016 | |||||||
|
0.645 | 0.640 | 13 | 46897343 | upstream gene variant | C/T | snv | 0.40 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.645 | 0.640 | 13 | 46897343 | upstream gene variant | C/T | snv | 0.40 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.645 | 0.640 | 13 | 46897343 | upstream gene variant | C/T | snv | 0.40 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.645 | 0.640 | 13 | 46897343 | upstream gene variant | C/T | snv | 0.40 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.645 | 0.640 | 13 | 46897343 | upstream gene variant | C/T | snv | 0.40 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.645 | 0.640 | 13 | 46897343 | upstream gene variant | C/T | snv | 0.40 |
|
0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.645 | 0.640 | 13 | 46897343 | upstream gene variant | C/T | snv | 0.40 |
|
0.010 | < 0.001 | 1 | 2014 | 2014 | ||||||||
|
0.645 | 0.640 | 13 | 46897343 | upstream gene variant | C/T | snv | 0.40 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.645 | 0.640 | 13 | 46897343 | upstream gene variant | C/T | snv | 0.40 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | < 0.001 | 1 | 2014 | 2014 | |||||||
|
0.645 | 0.640 | 13 | 46897343 | upstream gene variant | C/T | snv | 0.40 |
|
Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.645 | 0.640 | 13 | 46897343 | upstream gene variant | C/T | snv | 0.40 |
|
Nervous System Diseases; Mental Disorders | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.645 | 0.640 | 13 | 46897343 | upstream gene variant | C/T | snv | 0.40 |
|
0.010 | 1.000 | 1 | 2006 | 2006 | ||||||||
|
0.645 | 0.640 | 13 | 46897343 | upstream gene variant | C/T | snv | 0.40 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.645 | 0.640 | 13 | 46897343 | upstream gene variant | C/T | snv | 0.40 |
|
Mental Disorders | 0.010 | < 0.001 | 1 | 2013 | 2013 | |||||||
|
0.645 | 0.640 | 13 | 46897343 | upstream gene variant | C/T | snv | 0.40 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.645 | 0.640 | 13 | 46897343 | upstream gene variant | C/T | snv | 0.40 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.645 | 0.640 | 13 | 46897343 | upstream gene variant | C/T | snv | 0.40 |
|
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Mental Disorders; Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.645 | 0.640 | 13 | 46897343 | upstream gene variant | C/T | snv | 0.40 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Eye Diseases; Male Urogenital Diseases; Nervous System Diseases; Endocrine System Diseases; Otorhinolaryngologic Diseases | 0.010 | 1.000 | 1 | 2006 | 2006 |